Stock market weakness to persist; selective approach key: Rahul Shah
So, if you look at the way the capital goods stocks were performing versus what they are now, so it is clearly a trend that 7% kind of a growth earlier which was 20 plus two years back.
Why you need not say goodbye to capex and invest only in consumption theme now
Prashant Khemka, Founder of White Oak Capital Management, anticipates a shift in performance between cyclical and defensive stocks. The Budget may reinforce this phenomenon. Khemka advises maintaining a balanced portfolio, emphasizing stock picking over top-down calls. He also notes the potential positive impact of income tax savings on demand and broad sectoral benefits.
Gland Pharma shares fall over 4% after weak Q3 result, Jefferies target price cut
Gland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 crore, with margins improving by 300 basis points to 26%. R&D expenses were Rs 43.7 crore, making up 4.3% of the revenue.
Dr Agarwal’s Health Care IPO listing today. Check GMP ahead of the debut
Dr Agarwal’s Health Care’s upcoming listing worries investors due to a discounted grey market premium and muted subscription. Despite being India’s largest eye care chain, with a 25% market share in FY24, and significant revenue and efficiency growth, market conditions appear challenging. Analysts recommend a long-term investment view for potential gains.
India in early stages of shift towards passive funds: Morningstar CEO Kunal Kapoor
The Indian Mutual Fund industry has come a long way over the past decade. Proactive regulations on disclosures, fund categorization and fees have driven positive change. Increased retail investor participation has also been fuelled by the industry’s efforts to promote investor awareness and education, broadening the reach of mutual funds across the country and investor […]
Stocks to buy: Power Grid, Divis Labs and Tata Chemicals on investors’ radar
Benchmark indices closed lower on Monday amid concerns over US tariffs. Key stocks in focus included Power Grid, which showed weakness, Divis Laboratories, which demonstrated strength, and Tata Chemicals, which tested crucial support zones. Recommendations for cautious trade approaches were provided for each stock.
Q3 results today: Titan, Asian Paints among 129 companies that will announce earnings on Tuesday
Titan is expected to see strong sales growth in Q3 due to festive demand and wedding season, though profitability may be muted by inventory loss. Asian Paints, however, may report a decline in revenue and net profit due to lower volumes and adverse pricing trends.
Power Grid shares in focus after co posts 4% YoY drop in Q3 profit, declares Rs 3.25/sh dividend
Power Grid Corporation of India reported a 4% year-on-year decline in net profit for the December 2024 quarter to Rs 3,861.63 crore. Total income also saw a slight decrease, while expenses were reduced. The company announced a second interim dividend and approved a significant investment project.
Rupee bleeds on trade war fears, falls below 87/$
The rupee opened at 87.03/$1 on Monday and weakened to 87.285/$1 in early trading, before it erased some losses toward the end of the trading session. The rupee had closed at 86.6/$1 on Friday.
Asian shares advance after Trump delays tariffs
Stocks in Australia and Japan gained, while contracts for Hong Kong stocks also looked up. US futures rose after the S&P 500 on Monday trimmed most of its slide that earlier approached 2%.